Welcome to another blog post for the weekly nootropic ingredient spotlight series.
Today we are taking a look at one of the most popular nootropic compounds available, CDP Choline.
CDP Choline, or otherwise known as Citicoline, is one of three compounds that can be supplemented as a form of dietary choline to help synthesise Acetylcholine (a neurotransmitter responsible for neuromuscular control, as well as learning and memory). The other two compounds being Alpha-GPC and Choline Bitartrate.
CDP-Choline is used at a dose of 300mg per serve in Enhance Nootropic.
Citicholine is a water soluble molecule, with more than 90% oral bioavailability. Peak plasma levels occur one hour after oral ingestion. Doses of up to 2000mg have been observed in humans and animals without causing any toxicity.
Supplementation with citicoline can increase the amount of choline available for acetylcholine synthesis and aid in rebuilding membrane phospholipid stores after depletion.
Both in animals and in human beings, citicoline has been shown to possess proved neuroprotective properties.
The usual daily therapeutic dosage of citicoline in humans is 500–2,000 mg.
We have opted in for 300mg per serve to ensure that no negative side effects become largely present which can occur with higher doses. High doses of choline sources are known to cause headaches.
CDP Choline or Citicoline works primarily via the following mechanisms of action:
In one study, 24 elderly patients with memory deficits were administered either 1000mg/day or 500mg/day of citicoline over a period of 4 weeks. These subjects saw a significantly improved memory in free recall tasks as compared to placebo. Similar results were found in 3 subgroups of treatment. This indicates that citicoline can posses memory enhancing effects in the range of 300-1000mg per day.
Another study investigated the safety and efficacy of citicoline in patients with Alzheimer's disease. 30 patients were given either 1000mg/day of Citicoline or placebo for 12 weeks. Citicoline was shown to increase cognitive performance in Alzheimer's disease patients and was shown to increase cerebral blood flow velocities. These patients also saw an increase in brain bioelectrical activity of alpha waves and theta waves, with a decrease in delta waves.
In another study, Citicoline was administered to healthy older subjects at a dose of 500mg/day for 6 weeks. Brain phospholipid synthesis increased by 7.3% in these 6 weeks.
One review also stated that CDP Choline has been shown to improve expression of SIRT1 protein, which is strongly involved in its neuroprotective effects.
Citicoline has a lot of promising clinical data to back its efficacy, however most of the data is limited to the elderly or those suffering with brain impairments. We think this is an essential nutrient to supplement with if you really want to preserve your brain over the long term, and minimise neurodegeneration due to aging or disease. We would love to see more studies with healthy or younger adults, as well as trials with a large cohort (number of participants) to continue to validate its efficacy.
9. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion - PubMed (nih.gov)
Comments will be approved before showing up.